Evidence map›Paper›PMID 21874021›Full record

ArticleNature2011

Innate immune recognition of bacterial ligands by NAIPs determines inflammasome specificity.

Eric M Kofoed, Russell E Vance

Open access · greenAbstract read
In one paragraph

Article in Nature, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 551 papers.

0numbers the graph read from it
0cells of the map it votes in
551citing papers in PubMed
34.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

551 citing papers in PubMed, 874 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Innate immunity: current understandings and future perspectives.Signal transduction and targeted therapy · 2026
    Review
  6. Article
  7. Article
  8. Pyroptosis: Molecular mechanisms and function.Journal of physiology and biochemistry · 2026
    Review
  9. Review
  10. Article
  11. Review
  12. Review
  13. A century of cell death research.Journal of cell science · 2026
    Review
  14. Review
  15. Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  16. Review
  17. Article
  18. Supramolecular Assemblies Drive Activation of Inflammasomes.Advances in experimental medicine and biology · 2026
    Review
  19. Review
  20. Review

491 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Eric M KofoedDivision of Immunology and Pathogenesis, Department of Molecular and Cell Biology, University of California, Berkeley, California 94720, USA.
Russell E Vance
University of California, Berkeley · US

Funding

The role of Listeria cyclic-di-AMP during infection and immunityP01AI063302 · NIAID · UNIVERSITY OF CALIFORNIA BERKELEY · PI STANLEY, SARAH A · 2004 to 2025
$45.5M
Functional and Structural Dissection of Inflammasome ActivationR37AI075039 · NIAID · UNIVERSITY OF CALIFORNIA BERKELEY · PI RUSSELL E VANCE · 2018 to 2026
$3.8M
Specificity and in vivo function of the Naip/Nlrc4 inflammasomesR01AI075039 · NIAID · UNIVERSITY OF CALIFORNIA BERKELEY · PI VANCE, RUSSELL E · 2008 to 2017
$3.6M
Macrophage transcriptional responses to Legionella pneumophilaR01AI080749 · NIAID · UNIVERSITY OF CALIFORNIA BERKELEY · PI VANCE, RUSSELL E · 2009 to 2013
$1.6M
NIAID NIH HHS AI063302NIAID NIH HHS AI075039NIAID NIH HHS AI080749NIAID NIH HHS P01 AI063302NIAID NIH HHS R01 AI075039NIAID NIH HHS R01 AI080749NIAID NIH HHS R37 AI075039
6 · The paper itself

Abstract

Inflammasomes are a family of cytosolic multiprotein complexes that initiate innate immune responses to pathogenic microbes by activating the caspase 1 protease. Although genetic data support a critical role for inflammasomes in immune defence and inflammatory diseases, the molecular basis by which individual inflammasomes respond to specific stimuli remains poorly understood. The inflammasome that contains the NLRC4 (NLR family, CARD domain containing 4) protein was previously shown to be activated in response to two distinct bacterial proteins, flagellin and PrgJ, a conserved component of pathogen-associated type III secretion systems. However, direct binding between NLRC4 and flagellin or PrgJ has never been demonstrated. A homologue of NLRC4, NAIP5 (NLR family, apoptosis inhibitory protein 5), has been implicated in activation of NLRC4 (refs 7-11), but is widely assumed to have only an auxiliary role, as NAIP5 is often dispensable for NLRC4 activation. However, Naip5 is a member of a small multigene family, raising the possibility of redundancy and functional specialization among Naip genes. Here we show in mice that different NAIP paralogues determine the specificity of the NLRC4 inflammasome for distinct bacterial ligands. In particular, we found that activation of endogenous NLRC4 by bacterial PrgJ requires NAIP2, a previously uncharacterized member of the NAIP gene family, whereas NAIP5 and NAIP6 activate NLRC4 specifically in response to bacterial flagellin. We dissected the biochemical mechanism underlying the requirement for NAIP proteins by use of a reconstituted NLRC4 inflammasome system. We found that NAIP proteins control ligand-dependent oligomerization of NLRC4 and that the NAIP2-NLRC4 complex physically associates with PrgJ but not flagellin, whereas NAIP5-NLRC4 associates with flagellin but not PrgJ. Our results identify NAIPs as immune sensor proteins and provide biochemical evidence for a simple receptor-ligand model for activation of the NAIP-NLRC4 inflammasomes.

Indexed as

AnimalsAntigens, BacterialApoptosis Regulatory ProteinsBacteriaCalcium-Binding ProteinsCaspase 1Cells, CulturedFlagellinHEK293 CellsHumansImmunity, InnateInflammasomesLigandsMacrophagesMiceMice, Inbred C57BLAntigens, BacterialApoptosis Regulatory ProteinsCalcium-Binding ProteinsCaspase 1FlagellinInflammasomesIpaf protein, mouseLigandsNaip2 protein, mouseNaip5 protein, mouseNeuronal Apoptosis-Inhibitory Protein

Identifiers

PMID21874021
PMCPMC3184209
OpenAlexW1988197452

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.